Clinical trial Galahad
A phase 2 efficacy and safety study of Niraparib in men with metastatic castration-resistant prostate cancer and DNA repair anomalies.
| Cancers | |
|---|---|
| Organ | prostate |
| Trial status | Trial closed |
| Investigator | |
| Trial type |
Interventional with experimental drug
|
| Phase | Trial phase 2 |
| Academic trial | Non |
| Sponsor | Janssen |
| EudraCT Identifier | 2016-002057-38 |
| ClinicalTrials.gov | https://clinicaltrials.gov/ct2/show/NCT02854436 |
| Inclusion criteria | 2nd line/ RECIST 1.1/ Biopsy |
| Last update |